Health & Safety Industry Today
Creatinine Test Market 2018–By Identifying the Key Market Segments and Key players holding market share through 2023
Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Creatinine Test Market Research Report - Global Forecast till 2023” Gives industry size, top players and worldwide demand
Published 01 June 2018
Market Synopsis of the Global Creatinine Test Market
Creatinine test measures the amount of creatinine in the kidney. Creatinine is excreted in the urine as a byproduct of creatine breakdown and is mainly found in the muscles. The test determines whether the kidney function is normal. Elevated creatinine levels signify kidney dysfunction as a result of kidney failure, kidney disease, and kidney infection. A number of devices are used for kidney function tests, such as analyzers, creatinine function test, and others.
Rising prevalence of chronic kidney disease, increasing demand for laboratory testing devices, and services accelerate the growth of the market. Furthermore, the demand for point-of-care testing services and extensive use of clinical testing devices and others, availability of creatinine test devices, and increasing demand for creatinine test are other important factors accelerating the growth of the market. Technological advancements in clinical testing devices also influence the market growth. The growth of the market is restrained by the accuracy of creatinine for diagnosis of kidney diseases.
Reqeust for Reports Sample @ https://www.marketresearchfuture.com/sample_request/4878
According to the WHO, about 59% of the mortality is due to chronic diseases and almost 35 million people die of chronic diseases in the world.
The global creatinine test market is expected to grow at a CAGR of 4.5% during the forecast period.
Segments
The global creatinine test market is segmented on the basis of type, indication, devices, and end user.
On the basis of the type, the market is segmented into urine test, blood test, and others.
On the basis of the devices & accessories, the market is segmented into clinical analyzer including bench top, and portable/ handheld analyzers, creatinine test strips, cartridge, and others.
On the basis of the indication, the market is segmented into kidney disease, kidney infection, kidney failure, urinary tract obstruction, and others.
On the basis of the end user, the market is segmented into hospital & clinics, diagnostic center, research institutes, and others.
Regional Analysis of the Global Creatinine Test Market
The Americas lead the global creatinine test market owing to the rising prevalence of chronic kidney disease in the U.S. Furthermore, the point-of-care testing is gaining roots in various parts of America, especially, in the U.S. and Canada. According to the National Chronic Kidney Disease Report, CKDs are common among adults in the U.S. It further stated that 30 million people or 15% of the US adults are estimated to have chronic kidney disease.
Europe is the second largest market for creatinine test. In Europe owing to increasing demand for point-of-care testing devices. The use of handheld or portable testing devices is found to be increasing with an increasing number of patients with kidney disease or renal failure. Furthermore, extensive research and development activities by clinical research and academic institutes further stimulate the growth of the market.
The Asia Pacific market is expected to grow at the fastest pace owing to the high prevalence of chronic disease such as kidney disease, obesity, diabetes, and other. The market is also driven by availability skilled professionals and increasing awareness about kidney diseases and importance of laboratory test in the diagnosis of kidney diseases. In Asia Pacific, kidney diseases are mostly associated with diabetes, changing lifestyle, and smoking, which lead to a number of kidney problems such as kidney failure.
The Middle East & Africa also shows a steady rise in the market owing to rising demand for diagnostic services, and growing emphasis on diagnosis and treatment of kidney disease. Developing healthcare infrastructure in the Middle East also fuels the growth of the market.
Request Full Report @ https://www.marketresearchfuture.com/reports/creatinine-test-market-4878
Key Players in the Global Creatinine tests Market
Some of the key players in this market are Quest Diagnostics (U.S.), Merck (U.S.), Sonic Healthcare (Australia), Bayer (U.S.), Beckman Coulter (U.S.), Laboratory Corporation of America Holdings (U.S.), Genoptix (U.S.), Healthscope (Australia), Labco (Kuwait), Charles River (U.S.), OPKO Health, Inc. (U.S.), amd Abbott (U.S.)
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Creatinine test measures the amount of creatinine in the kidney. Creatinine is excreted in the urine as a byproduct of creatine breakdown and is mainly found in the muscles. The test determines whether the kidney function is normal. Elevated creatinine levels signify kidney dysfunction as a result of kidney failure, kidney disease, and kidney infection. A number of devices are used for kidney function tests, such as analyzers, creatinine function test, and others.
Rising prevalence of chronic kidney disease, increasing demand for laboratory testing devices, and services accelerate the growth of the market. Furthermore, the demand for point-of-care testing services and extensive use of clinical testing devices and others, availability of creatinine test devices, and increasing demand for creatinine test are other important factors accelerating the growth of the market. Technological advancements in clinical testing devices also influence the market growth. The growth of the market is restrained by the accuracy of creatinine for diagnosis of kidney diseases.
Reqeust for Reports Sample @ https://www.marketresearchfuture.com/sample_request/4878
According to the WHO, about 59% of the mortality is due to chronic diseases and almost 35 million people die of chronic diseases in the world.
The global creatinine test market is expected to grow at a CAGR of 4.5% during the forecast period.
Segments
The global creatinine test market is segmented on the basis of type, indication, devices, and end user.
On the basis of the type, the market is segmented into urine test, blood test, and others.
On the basis of the devices & accessories, the market is segmented into clinical analyzer including bench top, and portable/ handheld analyzers, creatinine test strips, cartridge, and others.
On the basis of the indication, the market is segmented into kidney disease, kidney infection, kidney failure, urinary tract obstruction, and others.
On the basis of the end user, the market is segmented into hospital & clinics, diagnostic center, research institutes, and others.
Regional Analysis of the Global Creatinine Test Market
The Americas lead the global creatinine test market owing to the rising prevalence of chronic kidney disease in the U.S. Furthermore, the point-of-care testing is gaining roots in various parts of America, especially, in the U.S. and Canada. According to the National Chronic Kidney Disease Report, CKDs are common among adults in the U.S. It further stated that 30 million people or 15% of the US adults are estimated to have chronic kidney disease.
Europe is the second largest market for creatinine test. In Europe owing to increasing demand for point-of-care testing devices. The use of handheld or portable testing devices is found to be increasing with an increasing number of patients with kidney disease or renal failure. Furthermore, extensive research and development activities by clinical research and academic institutes further stimulate the growth of the market.
The Asia Pacific market is expected to grow at the fastest pace owing to the high prevalence of chronic disease such as kidney disease, obesity, diabetes, and other. The market is also driven by availability skilled professionals and increasing awareness about kidney diseases and importance of laboratory test in the diagnosis of kidney diseases. In Asia Pacific, kidney diseases are mostly associated with diabetes, changing lifestyle, and smoking, which lead to a number of kidney problems such as kidney failure.
The Middle East & Africa also shows a steady rise in the market owing to rising demand for diagnostic services, and growing emphasis on diagnosis and treatment of kidney disease. Developing healthcare infrastructure in the Middle East also fuels the growth of the market.
Request Full Report @ https://www.marketresearchfuture.com/reports/creatinine-test-market-4878
Key Players in the Global Creatinine tests Market
Some of the key players in this market are Quest Diagnostics (U.S.), Merck (U.S.), Sonic Healthcare (Australia), Bayer (U.S.), Beckman Coulter (U.S.), Laboratory Corporation of America Holdings (U.S.), Genoptix (U.S.), Healthscope (Australia), Labco (Kuwait), Charles River (U.S.), OPKO Health, Inc. (U.S.), amd Abbott (U.S.)
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
